Status:
UNKNOWN
Human Milk Fortification With Adjustable Versus Targeted Method
Lead Sponsor:
University of Calgary
Conditions:
Growth Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Research question: Do preterm infants born \<1250 g achieve better weight gain with targeted fortification compared with the adjustable fortification of human milk? Hypothesis: Targeted fortification...
Detailed Description
Human milk is the ideal diet for neonates. However, it does not provide enough energy, protein, and sodium to meet the nutritional requirements of very preterm infants. Postnatal growth failure is com...
Eligibility Criteria
Inclusion
- Infants with birth weight \<1250 g born at Foothills Medical Centre.
- Appropriate for gestational age (AGA) (according to Fenton's Charts).
Exclusion
- Abnormal Newborn Metabolic Screen
- Major congenital anomalies intervention.
- Patients who develop NEC prior to enrollment.
- Patients with confirmed congenital Toxoplasmosis, Syphilis, Rubella, Cytomegalovirus, Herpes simplex virus, Varicella and/or Zika (TORCH infections).
- Patients receiving systemic steroids.
- Patients with acute kidney injury (AKI).
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04809350
Start Date
November 10 2023
End Date
May 31 2025
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N2T9